Tactile Systems Technology, Inc. (NASDAQ:TCMD) Director Daniel L. Reuvers Sells 10,938 Shares

Tactile Systems Technology, Inc. (NASDAQ:TCMD - Get Free Report) Director Daniel L. Reuvers sold 10,938 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $14.55, for a total value of $159,147.90. Following the completion of the sale, the director now owns 242,942 shares of the company's stock, valued at approximately $3,534,806.10. This represents a 4.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Tactile Systems Technology Stock Up 0.6 %

TCMD traded up $0.08 on Friday, reaching $14.29. The company's stock had a trading volume of 236,510 shares, compared to its average volume of 295,235. Tactile Systems Technology, Inc. has a 1 year low of $11.12 and a 1 year high of $21.10. The business's 50 day moving average is $17.03 and its 200 day moving average is $15.71. The company has a debt-to-equity ratio of 0.11, a current ratio of 4.36 and a quick ratio of 3.80. The stock has a market cap of $337.03 million, a price-to-earnings ratio of 20.41 and a beta of 1.20.

Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) last released its earnings results on Tuesday, February 18th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.31 by $0.09. The company had revenue of $85.59 million during the quarter, compared to analysts' expectations of $85.39 million. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%. As a group, research analysts forecast that Tactile Systems Technology, Inc. will post 0.7 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in TCMD. Rhumbline Advisers raised its stake in shares of Tactile Systems Technology by 1.6% in the 4th quarter. Rhumbline Advisers now owns 38,033 shares of the company's stock valued at $651,000 after purchasing an additional 581 shares in the last quarter. Sterling Capital Management LLC raised its stake in Tactile Systems Technology by 2.8% during the fourth quarter. Sterling Capital Management LLC now owns 25,028 shares of the company's stock valued at $429,000 after buying an additional 683 shares in the last quarter. SG Americas Securities LLC raised its stake in Tactile Systems Technology by 12.7% during the fourth quarter. SG Americas Securities LLC now owns 12,032 shares of the company's stock valued at $206,000 after buying an additional 1,354 shares in the last quarter. Northern Trust Corp lifted its holdings in Tactile Systems Technology by 0.7% during the 4th quarter. Northern Trust Corp now owns 205,914 shares of the company's stock worth $3,527,000 after buying an additional 1,371 shares during the last quarter. Finally, Legal & General Group Plc grew its position in shares of Tactile Systems Technology by 33.2% in the 4th quarter. Legal & General Group Plc now owns 6,257 shares of the company's stock worth $107,000 after acquiring an additional 1,558 shares in the last quarter. 83.43% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

TCMD has been the subject of a number of recent research reports. B. Riley lowered Tactile Systems Technology from a "buy" rating to a "neutral" rating and lowered their target price for the company from $23.00 to $18.00 in a research note on Wednesday, February 19th. StockNews.com downgraded shares of Tactile Systems Technology from a "strong-buy" rating to a "buy" rating in a research report on Thursday, January 16th. Oppenheimer cut shares of Tactile Systems Technology from an "outperform" rating to a "market perform" rating in a research report on Tuesday, November 5th. Finally, BTIG Research lowered shares of Tactile Systems Technology from a "buy" rating to a "neutral" rating in a report on Tuesday, November 5th.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.